Bekir Hakan Bakkal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bekir Hakan Bakkal has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Meryem Akpolat
Zonguldak Bülent Ecevit Üniversitesi
3 shared publications - Özlem Elmas
Bulent Ecevit University, School of Medicine
3 shared publications - Fatma Ayca Gultekin
General Surgery Department Zonguldak Bulent Ecevit University School of Medicine Zonguldak Turkey
2 shared publications - Kanat Gülle
Süleyman Demirel University, Faculty of Medicine, Department of Histology and Embryology, Isparta, Türkiye
2 shared publications Ozlem Elmas
2 shared publications- Zehra Safi Oz
Department of Medical Biology, Faculty of Medicine, Zonguldak Bulent Ecevit University, 67600 Zonguldak, Türkiye
2 shared publications
Latest Publications
- Open Access
- 19 June 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (25) , e49314
Predictive value of a clinical score for overall survival following curative radiotherapy for lung cancer
This study retrospectively calculated the LabPS score (laboratory parameters + performance status) in patients with small-cell lung cancer (SCLC) and non-SCLC who were treated with curative radiotherapy. The score was derived from pretreatment laboratory parameters – including hemoglobin level, platelet count, serum lactate dehydrogenase, serum albumin, and serum C-reactive protein – and Eastern Cooperative Oncology Group (ECOG) performance status (PS). The primary aim was to investigate the association between the LabPS score and overall survival (OS). The LabPS score was calculated retrospectively by reviewing pretreatment routine complete blood counts, biochemistry results, and ECOG PS of patients diagnosed with lung cancer and treated with radiotherapy. Patients who underwent radiotherapy with curative intent were selected. Patients with metastatic lung cancer and ECOG PS ≥ 3 were excluded. The primary endpoint was determined as OS. When LabPS scores were evaluated using receiver operating characteristic curve analysis, patients were classified into 2 prognostic groups: “favorable” (≤1) and “unfavorable” (>1), with an area under the curve corresponding to a 95% confidence interval: 0.654 to 0.806. Patients were stratified according to both their TNM stage and LabPS score, and survival analyses were subsequently conducted. These analyses demonstrated that patients with early-stage disease and a favorable LabPS score had significantly longer OS. In this study, the LabPS score successfully stratified patients with SCLC and non-SCLC into prognostic groups, demonstrating significant survival differences between the favorable and unfavorable categories. These findings suggest that the LabPS score has potential for survival prediction. Because the LabPS score can be easily calculated using routine laboratory tests in combination with PS, it has the potential to serve as a practical and cost-effective tool in daily oncology practice, pending further validation in larger, prospective cohorts. If validated in future studies, this score may potentially assist in clinical decision-making, including the timing of chemoradiotherapy, radiation dose optimization, and the development of personalized treatment plans.
- 19 June 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (25) , e49314
Open AccessPredictive value of a clinical score for overall survival following curative radiotherapy for lung cancer
This study retrospectively calculated the LabPS score (laboratory parameters + performance status) in patients with small-cell lung cancer (SCLC) and non-SCLC who were treated with curative radiotherapy. The score was derived from pretreatment laboratory parameters – including hemoglobin level, platelet count, serum lactate dehydrogenase, serum albumin, and serum C-reactive protein – and Eastern Cooperative Oncology Group (ECOG) performance status (PS). The primary aim was to investigate the association between the LabPS score and overall survival (OS). The LabPS score was calculated retrospectively by reviewing pretreatment routine complete blood counts, biochemistry results, and ECOG PS of patients diagnosed with lung cancer and treated with radiotherapy. Patients who underwent radiotherapy with curative intent were selected. Patients with metastatic lung cancer and ECOG PS ≥ 3 were excluded. The primary endpoint was determined as OS. When LabPS scores were evaluated using receiver operating characteristic curve analysis, patients were classified into 2 prognostic groups: “favorable” (≤1) and “unfavorable” (>1), with an area under the curve corresponding to a 95% confidence interval: 0.654 to 0.806. Patients were stratified according to both their TNM stage and LabPS score, and survival analyses were subsequently conducted. These analyses demonstrated that patients with early-stage disease and a favorable LabPS score had significantly longer OS. In this study, the LabPS score successfully stratified patients with SCLC and non-SCLC into prognostic groups, demonstrating significant survival differences between the favorable and unfavorable categories. These findings suggest that the LabPS score has potential for survival prediction. Because the LabPS score can be easily calculated using routine laboratory tests in combination with PS, it has the potential to serve as a practical and cost-effective tool in daily oncology practice, pending further validation in larger, prospective cohorts. If validated in future studies, this score may potentially assist in clinical decision-making, including the timing of chemoradiotherapy, radiation dose optimization, and the development of personalized treatment plans.
- Open Access
- 30 April 2021
- Published by Tip Egitimi Dunyasi in Tıp Eğitimi Dünyası
- Vol. 20 (60-1) , 59-62
COVİD-19 Pandemisinde Zonguldak Bülent Ecevit Üniversitesi Tıp Fakültesinin Eğitim Deneyimi
Zonguldak Bülent Ecevit Üniversitesi Tıp Fakültesinde COVID-19 pandemi sürecinde eğitim deneyimlerimizi paylaşmayı amaçladık. Fakültemizde YÖK’ün 13 Mart 2020’de eğitim ilgili kararı sonrası tüm dönemlerde eğitim online dijital platformlar üzerinden senkron ve asenkron olarak başladı. Tüm sınavlar dijital platform üzerinden yapıldı. Bu süreçte hem öğretim üyeleri, hem de öğrencilerle düzenli aralıklarla dijital platformlar üzerinden toplantılar yapıldı ve geri bildirimleri alındı. Her ne kadar bu süreç içinde bazı yetersizlikler yaşandıysa da öğrenci ve öğretim üyelerinin adaptasyonu hızlı oldu. Eğitime ara verilmemesiyle öğrenci mağduriyeti yaşanmadı. Bundan sonraki süreçte uzaktan eğitimin tıp eğitiminin ayrılmaz bir parçası olacağını düşünmekteyiz.
- 30 April 2021
- Published by Tip Egitimi Dunyasi in Tıp Eğitimi Dünyası
- Vol. 20 (60-1) , 59-62
Open AccessCOVİD-19 Pandemisinde Zonguldak Bülent Ecevit Üniversitesi Tıp Fakültesinin Eğitim Deneyimi
Zonguldak Bülent Ecevit Üniversitesi Tıp Fakültesinde COVID-19 pandemi sürecinde eğitim deneyimlerimizi paylaşmayı amaçladık. Fakültemizde YÖK’ün 13 Mart 2020’de eğitim ilgili kararı sonrası tüm dönemlerde eğitim online dijital platformlar üzerinden senkron ve asenkron olarak başladı. Tüm sınavlar dijital platform üzerinden yapıldı. Bu süreçte hem öğretim üyeleri, hem de öğrencilerle düzenli aralıklarla dijital platformlar üzerinden toplantılar yapıldı ve geri bildirimleri alındı. Her ne kadar bu süreç içinde bazı yetersizlikler yaşandıysa da öğrenci ve öğretim üyelerinin adaptasyonu hızlı oldu. Eğitime ara verilmemesiyle öğrenci mağduriyeti yaşanmadı. Bundan sonraki süreçte uzaktan eğitimin tıp eğitiminin ayrılmaz bir parçası olacağını düşünmekteyiz.
- 3 April 2021
- Published by Bulent Evcevit University in Batı Karadeniz Tıp Dergisi
- Vol. 5 (1) , 63-67
A Comparison Between Modified Radical Mastectomy and Breast-Conserving Surgery Concerning the Quality of Life in Patients with Breast Cancer Under 50 Years of Age
Surgery (BCS) to those having undergone modified radical mastectomy (MRM). Material and Methods: Forty-four BCS and 27 MRM patients have been included in this retrospective study. All patients have completed adjuvant chemotherapies and radiation therapies. MRM patients who received breast reconstruction surgery afterwards, patients who experienced local or distant organ relapse, or patients over fifty years old have been excluded. Each patient’s quality of life has been evaluated using the Short Form 36 (SF-36), 6 months after the completion of their treatment. Results: Between BCS and MRM groups, no significant difference of age, height, weight and body mass index was observed. While the BCS group yielded better results from the SF-36 subscales, i.e. physical functioning, physical role functioning, emotional role functioning, social role functioning, bodily pain, and general health perceptions, the only measures illustrating a significant difference were vitality and mental health, in comparison of BCS with MRM group (p= 0.043 and p= 0.023, respectively). Conclusion: In the treatment of breast cancer, enhancing patients’ quality of life is just as essential as improving survivals. Our research demonstrates higher quality of life in BCS patients, highlighting the statistical difference of the vitality and mental health subscales of the SF-36, compared with the MRM group.
- 3 April 2021
- Published by Bulent Evcevit University in Batı Karadeniz Tıp Dergisi
- Vol. 5 (1) , 63-67
A Comparison Between Modified Radical Mastectomy and Breast-Conserving Surgery Concerning the Quality of Life in Patients with Breast Cancer Under 50 Years of Age
Surgery (BCS) to those having undergone modified radical mastectomy (MRM). Material and Methods: Forty-four BCS and 27 MRM patients have been included in this retrospective study. All patients have completed adjuvant chemotherapies and radiation therapies. MRM patients who received breast reconstruction surgery afterwards, patients who experienced local or distant organ relapse, or patients over fifty years old have been excluded. Each patient’s quality of life has been evaluated using the Short Form 36 (SF-36), 6 months after the completion of their treatment. Results: Between BCS and MRM groups, no significant difference of age, height, weight and body mass index was observed. While the BCS group yielded better results from the SF-36 subscales, i.e. physical functioning, physical role functioning, emotional role functioning, social role functioning, bodily pain, and general health perceptions, the only measures illustrating a significant difference were vitality and mental health, in comparison of BCS with MRM group (p= 0.043 and p= 0.023, respectively). Conclusion: In the treatment of breast cancer, enhancing patients’ quality of life is just as essential as improving survivals. Our research demonstrates higher quality of life in BCS patients, highlighting the statistical difference of the vitality and mental health subscales of the SF-36, compared with the MRM group.
- Open Access
- 8 January 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (1) , e24266
Dosimetric comparison of organs at risk in 5 different radiotherapy plans in patients with preoperatively irradiated rectal cancer
Background: Intensity-modulated radiotherapy (IMRT) is a widely used irradiation technique in rectal cancer patients. We aimed to compare 4 different IMRT plans with 3-dimensional conformal radiotherapy (3D-CRT) considering organs at risk (OARs) in patients with rectal carcinoma. Methods: This retrospective study included 27 rectal cancer patients who were irradiated preoperatively between January 2016 and December 2018. Five different plans (4-field 3D-CRT in 2 phases, 7-field IMRT in 2 phases, 9-field IMRT in 2 phases, 7-field simultaneous integrated boost [SIB] IMRT, and 9-field SIB IMRT) were generated for each patient. Comparison of 5 different plans according to bladder and bilateral femoral head mean doses, bladder V40, bilateral femoral head V40, and small bowel V35 values were evaluated. Results: Most of the OAR parameters significantly favored IMRT plans compared to the 3D-CRT plan. The largest difference was observed in bladder V40 values (reduction of V40 value up to 51.2% reduction) in favor of IMRT. In addition, SIB plans showed significantly better reduction in OARs than phase plans except for small bowel V35 values. Conclusions: IMRT plans reduced almost all the OARs doses compared with the 3D-CRT plan in rectal cancer patients. Furthermore, SIB plans demonstrated lower OAR doses than the phase plans. IMRT techniques, especially SIB plans, reduce OAR doses and provide safer doses for the treatment of rectal carcinoma.
- 8 January 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (1) , e24266
Open AccessDosimetric comparison of organs at risk in 5 different radiotherapy plans in patients with preoperatively irradiated rectal cancer
Background: Intensity-modulated radiotherapy (IMRT) is a widely used irradiation technique in rectal cancer patients. We aimed to compare 4 different IMRT plans with 3-dimensional conformal radiotherapy (3D-CRT) considering organs at risk (OARs) in patients with rectal carcinoma. Methods: This retrospective study included 27 rectal cancer patients who were irradiated preoperatively between January 2016 and December 2018. Five different plans (4-field 3D-CRT in 2 phases, 7-field IMRT in 2 phases, 9-field IMRT in 2 phases, 7-field simultaneous integrated boost [SIB] IMRT, and 9-field SIB IMRT) were generated for each patient. Comparison of 5 different plans according to bladder and bilateral femoral head mean doses, bladder V40, bilateral femoral head V40, and small bowel V35 values were evaluated. Results: Most of the OAR parameters significantly favored IMRT plans compared to the 3D-CRT plan. The largest difference was observed in bladder V40 values (reduction of V40 value up to 51.2% reduction) in favor of IMRT. In addition, SIB plans showed significantly better reduction in OARs than phase plans except for small bowel V35 values. Conclusions: IMRT plans reduced almost all the OARs doses compared with the 3D-CRT plan in rectal cancer patients. Furthermore, SIB plans demonstrated lower OAR doses than the phase plans. IMRT techniques, especially SIB plans, reduce OAR doses and provide safer doses for the treatment of rectal carcinoma.
- Open Access
- 1 July 2020
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 127, 110134
X irradiation induced colonic mucosal injury and the detection of apoptosis through PARP-1/p53 regulatory pathway
- 1 July 2020
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 127, 110134
Open AccessX irradiation induced colonic mucosal injury and the detection of apoptosis through PARP-1/p53 regulatory pathway
- Open Access
- 1 December 2018
- Published by Medical Journal of Suleyman Demirel University in SDÜ Tıp Fakültesi Dergisi
- Vol. 25 (4) , 370-384
Skrotal Radyoterapide Curcuminin Profilaktik Kullanımı Testis Dokusunda PARP-1 İmmünreaktivitesini ve Spermatogenezi Nasıl Etkiler?
Fertilitede akut doz radyasyonun öldürücü etkileri iyi bilinmektedir. Kısa süreli radyasyona maruziyet germ hücrelerinin ölümü ve hasarlanması ile sonuçlanır. Son yıllarda radyoterapi, kanserli hastaların uzun süreli iyileşmesine önemli ölçüde katkı vermiştir. Ancak radyasyonun uzun dönemde üreme sistemi üzerindeki hasarlayıcı etkisi ile meydana gelen fertilizasyon kayıplarını göz ardı etmemek gerekmektedir. Bu güne kadar curcuminin antioksidan ve radyoprotektif etkisi ile ilgili birçok makale yayınlanmıştır. Bu çalışma; curcuminin X ışınlamayı takiben sıçan testisinde ortaya çıkacak germ hücre kaybı ile ilişkili infertiliteyi iyileştirebileceği düşüncesi ile planlanmıştır. Çalışmamızda biri kontrol 3’ü deney grubu olmak üzere toplam 4 grup oluşturuldu. Radyasyon hasarı oluşturmak amacıyla kontrol ve curcumin grubu dışındaki deneklerin skrotal bölgelerine tek fraksiyonda 6 Gy X ışını uygulandı. Curcumin ve radyasyon+ curcumin gruplarına; ışınlamadan 1 hafta önce başlayarak, haftada 3 kez olmak üzere 7 hafta boyunca oral yoldan 100 mg/kg curcumin, kontrol ve radyasyon gruplarına da aynı şekilde serum fizyolojik verildi. Işınlamadan 6 hafta sonra tüm denekler sakrifiye edildi ve alınan testis biyopsi materyalleri histopatolojik incelemeler için işlemlendirildi. Çalışmamızda, iyonize radyasyonun tübüllerin çoğunda germ hücre kaybına bağlı olarak, tübüler atrofiye neden olduğu görüldü. Radyasyon alan deneklerin tümünde, spermatogenezisin bozulması ile ilişkili olarak, Jhonsen skorunda kontrole göre anlamlı düzeyde (p<0,05) azalma saptandı. PARP-1 immünreaktivite skorunda da hasarının şiddeti ile ilişkili olarak, kontrole göre anlamlı düzeyde (p<0,05) artış belirlendi. Curcumin uygulamasının ise radyasyona bağlı ortaya çıkan hasarları önlemede beklenen düzeyde koruma ve iyileşme sağlamadığı tespit edildi.
- 1 December 2018
- Published by Medical Journal of Suleyman Demirel University in SDÜ Tıp Fakültesi Dergisi
- Vol. 25 (4) , 370-384
Open AccessSkrotal Radyoterapide Curcuminin Profilaktik Kullanımı Testis Dokusunda PARP-1 İmmünreaktivitesini ve Spermatogenezi Nasıl Etkiler?
Fertilitede akut doz radyasyonun öldürücü etkileri iyi bilinmektedir. Kısa süreli radyasyona maruziyet germ hücrelerinin ölümü ve hasarlanması ile sonuçlanır. Son yıllarda radyoterapi, kanserli hastaların uzun süreli iyileşmesine önemli ölçüde katkı vermiştir. Ancak radyasyonun uzun dönemde üreme sistemi üzerindeki hasarlayıcı etkisi ile meydana gelen fertilizasyon kayıplarını göz ardı etmemek gerekmektedir. Bu güne kadar curcuminin antioksidan ve radyoprotektif etkisi ile ilgili birçok makale yayınlanmıştır. Bu çalışma; curcuminin X ışınlamayı takiben sıçan testisinde ortaya çıkacak germ hücre kaybı ile ilişkili infertiliteyi iyileştirebileceği düşüncesi ile planlanmıştır. Çalışmamızda biri kontrol 3’ü deney grubu olmak üzere toplam 4 grup oluşturuldu. Radyasyon hasarı oluşturmak amacıyla kontrol ve curcumin grubu dışındaki deneklerin skrotal bölgelerine tek fraksiyonda 6 Gy X ışını uygulandı. Curcumin ve radyasyon+ curcumin gruplarına; ışınlamadan 1 hafta önce başlayarak, haftada 3 kez olmak üzere 7 hafta boyunca oral yoldan 100 mg/kg curcumin, kontrol ve radyasyon gruplarına da aynı şekilde serum fizyolojik verildi. Işınlamadan 6 hafta sonra tüm denekler sakrifiye edildi ve alınan testis biyopsi materyalleri histopatolojik incelemeler için işlemlendirildi. Çalışmamızda, iyonize radyasyonun tübüllerin çoğunda germ hücre kaybına bağlı olarak, tübüler atrofiye neden olduğu görüldü. Radyasyon alan deneklerin tümünde, spermatogenezisin bozulması ile ilişkili olarak, Jhonsen skorunda kontrole göre anlamlı düzeyde (p<0,05) azalma saptandı. PARP-1 immünreaktivite skorunda da hasarının şiddeti ile ilişkili olarak, kontrole göre anlamlı düzeyde (p<0,05) artış belirlendi. Curcumin uygulamasının ise radyasyona bağlı ortaya çıkan hasarları önlemede beklenen düzeyde koruma ve iyileşme sağlamadığı tespit edildi.
- 1 October 2014
- Published by AVES YAYINCILIK A.Ş. in The Medical Journal of Okmeydani Training and Research Hospital
- Vol. 30 (3) , 139-145
Mide Kanserli Hastalarda Postoperatif Kemoradyoterapi Sonuçları: Bülent Ecevit Üniversitesi Deneyimi
- 1 October 2014
- Published by AVES YAYINCILIK A.Ş. in The Medical Journal of Okmeydani Training and Research Hospital
- Vol. 30 (3) , 139-145
Mide Kanserli Hastalarda Postoperatif Kemoradyoterapi Sonuçları: Bülent Ecevit Üniversitesi Deneyimi
- 1 January 2014
- Published by Medknow in Journal of Cancer Research and Therapeutics
- Vol. 10 (3) , 558-62
Effect of treatment position and radiotherapy planning on testicular dose in patients with rectal carcinoma
And Spearman correlation analysis. Results: Median cumulative testicular doses of s4f, p4f, and p3f plans were 19.8, 69.3, and 100.8 cGy, respectively (P = 0.013). Median V0.5 (Volume receiving more than 0.5 Gy) and V1 (Volume receiving more than 1 Gy) for testicles were also significantly lower in s4f plans (3%, 60.7%, and 78.1% for V0.5 and 0.3%, 35.8%, and 52.3% for V1 in s4f, p4f, and p3f, respectively) (P = 0.001). The median distances between lower edge of fields and testicles in s4f, p4f, and p3f plans were 65 mm, 29 mm, and 29 mm, respectively (P < 0.01). Median bladder doses were significantly lower in p3f plans (P = 0.002). Conclusions: S4f external beam radiotherapy for rectal carcinoma allows better testicular dose than p3f and p4f. The probably reason was the increase of distance between lower edge of the field and testicles....
- 1 January 2014
- Published by Medknow in Journal of Cancer Research and Therapeutics
- Vol. 10 (3) , 558-62
Effect of treatment position and radiotherapy planning on testicular dose in patients with rectal carcinoma
And Spearman correlation analysis. Results: Median cumulative testicular doses of s4f, p4f, and p3f plans were 19.8, 69.3, and 100.8 cGy, respectively (P = 0.013). Median V0.5 (Volume receiving more than 0.5 Gy) and V1 (Volume receiving more than 1 Gy) for testicles were also significantly lower in s4f plans (3%, 60.7%, and 78.1% for V0.5 and 0.3%, 35.8%, and 52.3% for V1 in s4f, p4f, and p3f, respectively) (P = 0.001). The median distances between lower edge of fields and testicles in s4f, p4f, and p3f plans were 65 mm, 29 mm, and 29 mm, respectively (P < 0.01). Median bladder doses were significantly lower in p3f plans (P = 0.002). Conclusions: S4f external beam radiotherapy for rectal carcinoma allows better testicular dose than p3f and p4f. The probably reason was the increase of distance between lower edge of the field and testicles....
- Open Access
- 1 September 2013
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 46 (9) , 789-796
Effect of ozone oxidative preconditioning in preventing early radiation-induced lung injury in rats
Ionizing radiation causes its biological effects mainly through oxidative damage induced by reactive oxygen species. Previous studies showed that ozone oxidative preconditioning attenuated pathophysiological events mediated by reactive oxygen species. As inhalation of ozone induces lung injury, the aim of this study was to examine whether ozone oxidative preconditioning potentiates or attenuates the effects of irradiation on the lung. Rats were subjected to total body irradiation, with or without treatment with ozone oxidative preconditioning (0.72 mg/kg). Serum proinflammatory cytokine levels, oxidative damage markers, and histopathological analysis were compared at 6 and 72 h after total body irradiation. Irradiation significantly increased lung malondialdehyde levels as an end-product of lipoperoxidation. Irradiation also significantly decreased lung superoxide dismutase activity, which is an indicator of the generation of oxidative stress and an early protective response to oxidative damage. Ozone oxidative preconditioning plus irradiation significantly decreased malondialdehyde levels and increased the activity of superoxide dismutase, which might indicate protection of the lung from radiation-induced lung injury. Serum tumor necrosis factor alpha and interleukin-1 beta levels, which increased significantly following total body irradiation, were decreased with ozone oxidative preconditioning. Moreover, ozone oxidative preconditioning was able to ameliorate radiation-induced lung injury assessed by histopathological evaluation. In conclusion, ozone oxidative preconditioning, repeated low-dose intraperitoneal administration of ozone, did not exacerbate radiation-induced lung injury, and, on the contrary, it provided protection against radiation-induced lung damage.
- 1 September 2013
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 46 (9) , 789-796
Open AccessEffect of ozone oxidative preconditioning in preventing early radiation-induced lung injury in rats
Ionizing radiation causes its biological effects mainly through oxidative damage induced by reactive oxygen species. Previous studies showed that ozone oxidative preconditioning attenuated pathophysiological events mediated by reactive oxygen species. As inhalation of ozone induces lung injury, the aim of this study was to examine whether ozone oxidative preconditioning potentiates or attenuates the effects of irradiation on the lung. Rats were subjected to total body irradiation, with or without treatment with ozone oxidative preconditioning (0.72 mg/kg). Serum proinflammatory cytokine levels, oxidative damage markers, and histopathological analysis were compared at 6 and 72 h after total body irradiation. Irradiation significantly increased lung malondialdehyde levels as an end-product of lipoperoxidation. Irradiation also significantly decreased lung superoxide dismutase activity, which is an indicator of the generation of oxidative stress and an early protective response to oxidative damage. Ozone oxidative preconditioning plus irradiation significantly decreased malondialdehyde levels and increased the activity of superoxide dismutase, which might indicate protection of the lung from radiation-induced lung injury. Serum tumor necrosis factor alpha and interleukin-1 beta levels, which increased significantly following total body irradiation, were decreased with ozone oxidative preconditioning. Moreover, ozone oxidative preconditioning was able to ameliorate radiation-induced lung injury assessed by histopathological evaluation. In conclusion, ozone oxidative preconditioning, repeated low-dose intraperitoneal administration of ozone, did not exacerbate radiation-induced lung injury, and, on the contrary, it provided protection against radiation-induced lung damage.